CS
BLFS icon

Credit Suisse’s BioLife Solutions BLFS Stock Holding History

Credit Suisse’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$673K Buy
36,281
+331
+0.9% +$5.79K ﹤0.01% 2494
2023
Q4 		$584K Buy
35,950
+429
+1% +$5.47K ﹤0.01% 2652
2023
Q3 		$491K Sell
35,521
-3,632
-9% -$57.2K ﹤0.01% 2697
2023
Q2 		$865K Buy
39,153
+10,535
+37% +$222K ﹤0.01% 2487
2023
Q1 		$622K Buy
28,618
+9
+0% +$202 ﹤0.01% 2623
2022
Q4 		$521K Sell
28,609
-1,587
-5% -$32.8K ﹤0.01% 2756
2022
Q3 		$687K Buy
30,196
+6,737
+29% +$144K ﹤0.01% 2593
2022
Q2 		$323K Buy
23,459
+2,460
+12% +$36.1K ﹤0.01% 3123
2022
Q1 		$477K Buy
20,999
+1,392
+7% +$36.6K ﹤0.01% 3011
2021
Q4 		$732K Buy
19,607
+1,488
+8% +$63.9K ﹤0.01% 3553
2021
Q3 		$767K Buy
18,119
+2,429
+15% +$117K ﹤0.01% 3531
2021
Q2 		$698K Sell
15,690
-4,023
-20% -$142K ﹤0.01% 3626
2021
Q1 		$709K Sell
19,713
-4,286
-18% -$169K ﹤0.01% 3543
2020
Q4 		$957K Buy
+23,999
New +$818K ﹤0.01% 3374
2016
Q3 		– Sell
-220,548
Closed -$352K – 4087
2016
Q2 		$352K Hold
220,548
– – ﹤0.01% 3619
2016
Q1 		$404K Sell
220,548
-19
-0% -$35 ﹤0.01% 3364
2015
Q4 		$478K Buy
220,567
+19
+0% +$43 ﹤0.01% 3416
2015
Q3 		$466K Hold
220,548
– – ﹤0.01% 3448
2015
Q2 		$430K Hold
220,548
– – ﹤0.01% 3817
2015
Q1 		$356K Hold
220,548
– – ﹤0.01% 3759
2014
Q4 		$362K Hold
220,548
– – ﹤0.01% 3940
2014
Q3 		$464K Buy
220,548
+110,274
+100% +$263K ﹤0.01% 3688
2014
Q2 		$251K Buy
+110,274
New +$298K ﹤0.01% 4221

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Credit Suisse's BLFS Position: Q1 2024 in Review

Credit Suisse increased its BioLife Solutions (BLFS) stake by 0.92% in Q1 2024, buying an estimated $5.79K and bringing the position to 36,281 shares worth $673K. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Credit Suisse first reported a position in BLFS in Q2 2014 and has held it in 23 quarters since. The position peaked at $957K in Q4 2020. 149 funds tracked by Wall St. Rank hold BLFS as of Q1 2024.

  • Credit Suisse held 36,281 shares of BioLife Solutions worth $673K as of Q1 2024.
  • Credit Suisse bought 331 BioLife Solutions shares in Q1 2024, an estimated $5.79K.
  • BioLife Solutions made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2494 holding.
  • Credit Suisse first reported a position in BioLife Solutions in Q2 2014 and has held it in 23 quarters since.
  • Credit Suisse's BioLife Solutions position peaked at $957K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.